NCT04303767

Brief Summary

Teeth selected for intervention with Atraumatic Restorative Treatment will receive Glass Ionomer restorations (control) or MI varnish (test) before receiving the Glass Ionomer restoration

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2020

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 11, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

March 11, 2020

Status Verified

March 1, 2020

Enrollment Period

5 months

First QC Date

March 3, 2020

Last Update Submit

March 7, 2020

Conditions

Keywords

Casein Phosphopeptide Amorphous Calcium PhosphateCPP-ACPcaries affected dentinedentine repairAtraumatic Restorative Treatment

Outcome Measures

Primary Outcomes (1)

  • Evaluate the reparative ability of Casein Phosphopeptide Amorphous Calcium Phosphate varnish on caries affected dentine in primary molars.

    this is by evaluating the clinical and radiographic data and also by descriptive histological assessment

    12 months

Other Outcomes (3)

  • Evaluate and compare the clinical outcome of Atraumatic Restorative Treatment with and without Casein Phosphopeptide Amorphous Calcium Phosphate varnish placed on caries affected dentine in primary molars to evaluate the restoration success or failure.

    12 months

  • Assess the radiographic success of Atraumatic Restorative Treatment with and without CPP-ACP varnish placed on caries affected dentine in primary molars by measuring the grey value radiographically using Image J software.

    12 months

  • Assess histologically the quality of the formed dentine using the Polarized Light Microscope and Scanning Electron Microscope.

    throughout the 12 months

Study Arms (2)

Test (ART + CPP-ACP)

EXPERIMENTAL

In this group, teeth selected will receive intervention with CPP-ACP and restorations with light cured Glass Ionomer restorations after excavating the carious lesions preserving the caries affected dentine using the ART

Drug: Casein phosphopeptide amorphous calcium phosphateProcedure: Atraumatic restorative treatment

Control (ART)

ACTIVE COMPARATOR

in this group, teeth selected will receive restorations with light cured Glass Ionomer restorations after excavating the carious lesions preserving the caries affected dentine using the ART

Procedure: Atraumatic restorative treatment

Interventions

varnish containing calcium and phospate ions which act as a source for tooth remineralization

Also known as: MI varnish
Test (ART + CPP-ACP)

excavation of dental caries and restoring with light cured Glass Ionomer Restoration

Also known as: ART
Control (ART)Test (ART + CPP-ACP)

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Healthy patients.
  • Patients with an age range of 6-8 years old for clinical evaluation.
  • Patients ranking definitely positive or positive on Frankl scale.
  • Patients having at least 1 symptomless primary molar with caries extending to the dentine (International Caries Detection and Assessment System (ICDAS II) code 4, 5 \& 6).
  • The presence of the permanent successors when examined by periapical X-ray.
  • Patients who will agree to participate in the study. For the ex-vivo sample
  • Patients with an age range of 9-11 years old.
  • The selected teeth should have more than half of their roots physiologically resorbed when examined by periapical X-ray.

You may not qualify if:

  • Patients with special health care needs (physical, mental or medical).
  • Primary molars that are mobile, ankylosed or have periapical pathology on initial examination clinically and radiographically.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Alexandria University

Alexandria, Egypt

Location

MeSH Terms

Conditions

Dental Caries

Interventions

casein phosphopeptide-amorphous calcium phosphate nanocomplexDental Atraumatic Restorative Treatment

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dentistry

Study Officials

  • Mohamed A. Bayoumi, MSc

    Pharos University in Alexandria

    PRINCIPAL INVESTIGATOR
  • Azza G. Hanno, Professor

    Alexandria University

    STUDY DIRECTOR
  • Karin M. Dowidar, Professor

    Alexandria University

    STUDY DIRECTOR
  • Samia S. Omar, Professor

    Alexandria University

    STUDY DIRECTOR

Central Study Contacts

Mohamed A. Bayoumi, MSc

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

March 3, 2020

First Posted

March 11, 2020

Study Start

March 1, 2020

Primary Completion

August 1, 2020

Study Completion

February 1, 2021

Last Updated

March 11, 2020

Record last verified: 2020-03

Locations